Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M604367200 on January 16, 2007

J. Biol. Chem., Vol. 282, Issue 10, 7164-7171, March 9, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
282/10/7164    most recent
M604367200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, J.
Right arrow Articles by Roy, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, J.
Right arrow Articles by Roy, S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Transcriptional and Epigenetic Regulation of Interleukin-2 Gene in Activated T Cells by Morphine*

Jinghua Wang{ddagger}, Roderick A. Barke§, and Sabita Roy{ddagger}§1

From the {ddagger}Department of Pharmacology, University of Minnesota, Minneapolis, Minnesota 55455 and the §Department of Surgery, Veterans Affairs Medical Center, Minneapolis, Minnesota 55417

Chronic morphine inhibits interleukin-2 (IL-2) at both the transcriptional and protein synthesis levels. The molecular mechanisms by which morphine decreases IL-2 are not fully understood. The production of IL-2 is tightly regulated by several transcription factors that bind to the IL-2 promoter. Herein, we show that chronic morphine treatment results in an increase in cAMP levels with a concurrent up-regulation of the cAMP inducible repressor inducible cAMP early repressor (ICER)/cAMP response element modulator (CREM) and down-regulation of p-cAMP-response element-binding protein (CREB) in activated T cells. Furthermore, ICER competes for p-CREB binding to the cAMP-responsive elements (CREs) site. This leads to the uncoupling of CBP/p300 thereby abrogating IL-2 transcription. Overexpression of either antisense CREM or CREB plasmid rescued morphine-induced inhibition of IL-2 promoter activity and protein production. In addition, we also found that chronic morphine treatment inhibited the acetylation and trimethylation of histones and decreased both DNA demethylation and accessibility of the IL-2 promoter. These findings suggest that chronic morphine treatment may function through both transcriptional and epigenetic mechanisms to inhibit IL-2 production.


Received for publication, May 8, 2006 , and in revised form, January 12, 2007.

* This work was supported by National Institutes of Health Grants RO1DA12104, KO2DA015349, and P50DA11806 (to S. R.) and, T32DA07097 (to J. W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 To whom correspondence should be addressed: Dept. of Pharmacology, University of Minnesota, 6-120 Jackson Hall, 321 Church St. S.E., Minneapolis, MN 55455. Tel.: 612-624-5983; Fax: 612-625-8408; E-mail: royxx002{at}umn.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
T. Fukuyama, L. H. Kasper, F. Boussouar, T. Jeevan, J. van Deursen, and P. K. Brindle
Histone Acetyltransferase CBP Is Vital To Demarcate Conventional and Innate CD8+ T-Cell Development
Mol. Cell. Biol., July 15, 2009; 29(14): 3894 - 3904.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
N. R. Webster and H. F. Galley
Immunomodulation in the critically ill
Br. J. Anaesth., July 1, 2009; 103(1): 70 - 81.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. Borner, J. Kraus, A. Bedini, B. Schraven, and V. Hollt
T-Cell Receptor/CD28-Mediated Activation of Human T Lymphocytes Induces Expression of Functional {micro}-Opioid Receptors
Mol. Pharmacol., August 1, 2008; 74(2): 496 - 504.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Wang, R. A. Barke, R. Charboneau, R. Schwendener, and S. Roy
Morphine Induces Defects in Early Response of Alveolar Macrophages to Streptococcus pneumoniae by Modulating TLR9-NF-{kappa}B Signaling
J. Immunol., March 1, 2008; 180(5): 3594 - 3600.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement